PEDIATRICS Vol. 86 No. 3 September 1990, pp. 350-356
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tal, A.
Right arrow Articles by Bearman, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tal, A.
Right arrow Articles by Bearman, J. E.

Methylprednisolone Therapy for Acute Asthma in Infants and Toddlers: A Controlled Clinical Trial

Asher Tal MD1, Nissim Levy MD1, and Jacob E. Bearman PhD1

1 Pediatric Division, Pediatric Pulmonology Unit, and Epidemiology Unit, Soroka Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel

A controlled double-blind trial was carried out to assess the effect of the early introduction of combined corticosteroid and beta-adrenergic drugs for the treatment of acute asthma in infants and toddlers. Seventy-four emergency room patients (aged 7 to 54 months) who were treated for acute asthma were studied. Treatment included, in addition to salbutamol inhalations, a single dose of intramuscular methylprednisolone (4 mg/kg) or normal saline as placebo. The patients were reevaluated 3 hours after initiation of treatment. At that time, patients were either admitted or discharged based on a clinical decision. Only 8 (20%) of 39 patients treated with steroids were admitted, compared with 15 (43%) of 35 in the placebo group (P < .05). Sequential analysis of 33 pairs, matched by age and severity of symptoms, revealed statistically significant reduced admission rates in patients treated with steroids. In the younger patients (6 to 24 months), admission rate was significantly lower for those treated with steroids (18%) as compared with those treated without steroids (50%) (P < .05). In the older group (24 to 54 months), the trend was similar but not statistically significant: 23% vs 31% in the steroid and placebo groups, respectively. These data indicate that corticosteroid treatment combined with an adrenergic agent, given early during an acute asthmatic episode, significantly reduces the hospital admission rate of infants and toddlers.

Submitted on April 4, 1989
Accepted on September 25, 1989




This article has been cited by other articles:


Home page
 PediatricsHome page
I. K. Kim, E. Phrampus, S. Venkataraman, R. Pitetti, A. Saville, T. Corcoran, E. Gracely, N. Funt, and A. Thompson
Helium/Oxygen-Driven Albuterol Nebulization in the Treatment of Children With Moderate to Severe Asthma Exacerbations: A Randomized, Controlled Trial
Pediatrics, November 1, 2005; 116(5): 1127 - 1133.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. R. McFadden Jr.
Acute Severe Asthma
Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 740 - 759.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. K. Nakanishi, A. K. Klasner, and B. K. Rubin
A Randomized Controlled Trial of Inhaled Flunisolide in the Management of Acute Asthma in Children
Chest, September 1, 2003; 124(3): 790 - 794.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
G. Rachelefsky
Treating Exacerbations of Asthma in Children: The Role of Systemic Corticosteroids
Pediatrics, August 1, 2003; 112(2): 382 - 397.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
L. Ciarallo, D. Brousseau, and S. Reinert
Higher-Dose Intravenous Magnesium Therapy for Children With Moderate to Severe Acute Asthma
Arch Pediatr Adolesc Med, October 1, 2000; 154(10): 979 - 983.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. Ploin, F. R. Chapuis, D. Stamm, J. Robert, L. David, P. G. Chatelain, G. Dutau, and D. Floret
High-Dose Albuterol by Metered-Dose Inhaler Plus a Spacer Device Versus Nebulization in Preschool Children With Recurrent Wheezing: A Double-Blind, Randomized Equivalence Trial
Pediatrics, August 1, 2000; 106(2): 311 - 317.
[Abstract] [Full Text]

Home page
 ChestHome page
C. L. Emerman, P. G. Woodruff, R. K. Cydulka, M. A. Gibbs, C. V. Pollack Jr., and C. A. Camargo Jr.
Prospective Multicenter Study of Relapse Following Treatment for Acute Asthma Among Adults Presenting to the Emergency Department
Chest, April 1, 1999; 115(4): 919 - 927.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
L. H Plotnick and F. M Ducharme
Should inhaled anticholinergics be added to beta 2 agonists for treating acute childhood and adolescent asthma? A systematic review
BMJ, October 10, 1998; 317(7164): 971 - 977.
[Abstract] [Full Text]

Home page
 PediatricsHome page
M. Weinberger;, T. Lieu, C. Quesenberry, and A. Capra
Preventing Hospital Admissions for Asthma
Pediatrics, May 1, 1998; 101 (5): 951 - 952.
[Full Text]